[{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H2K1", "country": "Canada", "phone": "416-346-7764", "website": "https://www.psyencebiomed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 50, "title": "Co-Founder, Executive Chairman & Strategic Business Development Officer", "yearBorn": 1974, "fiscalYear": 2025, "totalPay": 216667, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "age": 60, "title": "CEO & Director", "yearBorn": 1964, "fiscalYear": 2025, "totalPay": 390000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warwick Ron Corden-Lloyd", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2025, "totalPay": 195000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.99, "open": 10.3, "dayLow": 10.0, "dayHigh": 11.98, "regularMarketPreviousClose": 9.99, "regularMarketOpen": 10.3, "regularMarketDayLow": 10.0, "regularMarketDayHigh": 11.98, "payoutRatio": 0.0, "beta": 0.216, "trailingPE": 0.27538314, "volume": 214008, "regularMarketVolume": 214008, "averageVolume": 118845, "averageVolume10days": 144490, "averageDailyVolume10Day": 144490, "bid": 11.1, "ask": 13.18, "bidSize": 1, "askSize": 2, "marketCap": 8202168, "fiftyTwoWeekLow": 2.936, "fiftyTwoWeekHigh": 402.0, "fiftyDayAverage": 5.34896, "twoHundredDayAverage": 16.101055, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5315561, "profitMargins": 0.0, "floatShares": 71171, "sharesOutstanding": 713232, "sharesShort": 12872, "sharesShortPriorMonth": 15310, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.018, "heldPercentInsiders": 0.00483, "heldPercentInstitutions": 0.49685, "shortRatio": 0.28, "shortPercentOfFloat": 0.0183, "impliedSharesOutstanding": 713232, "bookValue": 94.317, "priceToBook": 0.121929236, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 1011790, "trailingEps": 41.76, "lastSplitFactor": "125:1000", "lastSplitDate": 1746403200, "enterpriseToEbitda": 1.453, "52WeekChange": -0.9690361, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 11.5, "recommendationKey": "none", "totalCash": 6135166, "totalCashPerShare": 86.083, "ebitda": -3658754, "totalDebt": 0, "quickRatio": 10.553, "currentRatio": 11.037, "returnOnAssets": -0.54196, "freeCashflow": -3394860, "operatingCashflow": -3734238, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PBM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639146600000, "corporateActions": [], "postMarketTime": 1753486591, "regularMarketTime": 1753473600, "exchange": "NCM", "messageBoardId": "finmb_698500412", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 15.115118, "regularMarketPrice": 11.5, "shortName": "Psyence Biomedical Ltd.", "longName": "Psyence Biomedical Ltd.", "postMarketChangePercent": -4.86957, "postMarketPrice": 10.94, "postMarketChange": -0.56, "regularMarketChange": 1.5100002, "regularMarketDayRange": "10.0 - 11.98", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 118845, "fiftyTwoWeekLowChange": 8.564, "fiftyTwoWeekLowChangePercent": 2.9168937, "fiftyTwoWeekRange": "2.936 - 402.0", "fiftyTwoWeekHighChange": -390.5, "fiftyTwoWeekHighChangePercent": -0.97139305, "fiftyTwoWeekChangePercent": -96.90361, "epsTrailingTwelveMonths": 41.76, "fiftyDayAverageChange": 6.15104, "fiftyDayAverageChangePercent": 1.1499506, "twoHundredDayAverageChange": -4.601055, "twoHundredDayAverageChangePercent": -0.2857611, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-01-26", "prevName": "Psyence Therapeutics Corp.", "nameChangeDate": "2025-07-25", "cryptoTradeable": false, "displayName": "Psyence Biomedical", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]